Pharmacokinetics of Meropenem in Patients with Cystic Fibrosis

@article{Christensson1998PharmacokineticsOM,
  title={Pharmacokinetics of Meropenem in Patients with Cystic Fibrosis},
  author={Bertil Christensson and Bengt Ljungberg and L. -O. Eriksson and Ingrid Nilsson-Ehle},
  journal={European Journal of Clinical Microbiology and Infectious Diseases},
  year={1998},
  volume={17},
  pages={873-876}
}
 The pharmacokinetics of meropenem were studied after single i.v. infusions of 15 mg meropenem/kg body weight in eight subjects with cystic fibrosis (CF) and eight healthy volunteers matched for age, sex, and weight. Significantly shorter terminal half-lives (mean, 0.74 h vs. 0.99 h) and mean residence times (mean, 1.09 h vs. 1.39 h) were noted in CF subjects. Plasma and renal clearances tended to be higher and distribution volumes smaller among the patients, but differences were not… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
7 Citations
15 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 15 references

The treatment of pulmonary infection in cystic fibrosis

  • AK Webb
  • Scandinavian Journal of Infectious Diseases
  • 1995
1 Excerpt

Enhanced ciprofloxacin clearance in cystic fibrosis (CF) patients

  • U Bentur, M Spino, +5 authors H Heurter
  • Clinical Pharmacology and Therapeutics
  • 1990
2 Excerpts

Similar Papers

Loading similar papers…